by in
Entry Author Date Location
Allon Therapeutics Adds $10M 11/01/10 Seattle
FDA Approves Sunovion Schizophrenia Drug 10/29/10 Boston
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News 10/15/10 Boston
A Nobel Laureate’s Stealthy Biotech, Its Japanese Pharma Backer, and the Englishman In Charge 10/14/10 Boston
BrainCells Inc. Buys Neuro Drug 08/04/10 San Diego
Alkermes Reveals Higher-Than-Expected Royalty on Diabetes Drug 04/26/10 Boston
Allon Treads Into the Great Unknown, Alzheimer’s Disease, With New Kind of Drug 04/06/10 Seattle
San Diego’s Acadia Pharmaceuticals Updates Plans for Experimental Parkinson’s Drug 03/10/10 San Diego
AFraxis CEO Outlines Biotech’s Success With Ultra-Lean Pre-Clinical R&D in Russia 02/26/10 San Diego
NIH Chief Stresses Economic Impact of Federal Biomedical Funding 02/22/10 San Diego
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood 02/04/10 Boston
Alkermes Bets $10M on Long-Lasting Drug Technology from Startup Neighbor, Acceleron 12/03/09 Boston
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day 10/08/09 Seattle
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say 08/26/09 Seattle
FDA OKs Risperdal Consta for Bipolar 05/18/09 Boston
Alkermes Knocks on Door of Biotech Big Leagues, Aims to Make Drugs of its Own 02/12/09 Boston
TheraGenetics Bought by Avacta 01/29/09 Boston
Omeros Grabs $3.1M 01/28/09 Seattle
Fidelity Biosciences Pumps $65M into EnVivo Pharma 10/31/08 Boston
Page 2 of 2 « previous page